209 related articles for article (PubMed ID: 16428159)
1. Use of etanercept in treatment of pyoderma gangrenosum in a patient with autoimmune hepatitis.
Goldenberg G; Jorizzo JL
J Dermatolog Treat; 2005; 16(5-6):347-9. PubMed ID: 16428159
[TBL] [Abstract][Full Text] [Related]
2. Etanercept for the treatment of refractory pyoderma gangrenosum: a brief series.
Charles CA; Leon A; Banta MR; Kirsner RS
Int J Dermatol; 2007 Oct; 46(10):1095-9. PubMed ID: 17910724
[TBL] [Abstract][Full Text] [Related]
3. Pyoderma gangrenosum treated with anti-TNF alpha therapy (etanercept).
Pastor N; Betlloch I; Pascual JC; Blanes M; Bañuls J; Silvestre JF
Clin Exp Dermatol; 2006 Jan; 31(1):152-3. PubMed ID: 16309525
[No Abstract] [Full Text] [Related]
4. Severe pyoderma gangrenosum unresponsive to etanercept and adalimumab.
Kleinpenning MM; Langewouters AM; Van De Kerkhof PC; Greebe RJ
J Dermatolog Treat; 2011 Oct; 22(5):261-5. PubMed ID: 20673157
[TBL] [Abstract][Full Text] [Related]
5. Treatment of pyoderma gangrenosum with etanercept.
McGowan JW; Johnson CA; Lynn A
J Drugs Dermatol; 2004; 3(4):441-4. PubMed ID: 15303791
[TBL] [Abstract][Full Text] [Related]
6. The treatment of pyoderma gangrenosum using etanercept.
Roy DB; Conte ET; Cohen DJ
J Am Acad Dermatol; 2006 Mar; 54(3 Suppl 2):S128-34. PubMed ID: 16488326
[No Abstract] [Full Text] [Related]
7. Treatment of pyoderma gangrenosum with the anti-TNFalpha drug - Etanercept.
Rogge FJ; Pacifico M; Kang N
J Plast Reconstr Aesthet Surg; 2008; 61(4):431-3. PubMed ID: 18358433
[TBL] [Abstract][Full Text] [Related]
8. The use of etanercept in the treatment of peristomal pyoderma gangrenosum.
Kim FS; Pandya AG
Clin Exp Dermatol; 2012 Jun; 37(4):442-3. PubMed ID: 22582915
[No Abstract] [Full Text] [Related]
9. Treatment of thalidomide resistant pyoderma gangrenosum with etenercept.
Guedes R; Moreira A; Menezes N; Baptista A; Varela P
Acta Dermatovenerol Croat; 2012; 20(3):175-80. PubMed ID: 23069303
[TBL] [Abstract][Full Text] [Related]
10. Clinical efficacy of etanercept for treatment of PAPA syndrome.
Tofteland ND; Shaver TS
J Clin Rheumatol; 2010 Aug; 16(5):244-5. PubMed ID: 20661073
[No Abstract] [Full Text] [Related]
11. Three-year registry data on biological treatment for psoriasis: the influence of patient characteristics on treatment outcome.
Driessen RJ; Boezeman JB; van de Kerkhof PC; de Jong EM
Br J Dermatol; 2009 Mar; 160(3):670-5. PubMed ID: 19210502
[TBL] [Abstract][Full Text] [Related]
12. Pyoderma gangrenosum with spleen involvement and monoclonal IgA gammopathy.
Mijuşković ZP; Zecević RD; Pavlović MD
J Eur Acad Dermatol Venereol; 2004 Nov; 18(6):697-9. PubMed ID: 15482299
[TBL] [Abstract][Full Text] [Related]
13. Paradoxical reaction to etanercept: development of pyoderma gangraenosum during therapy of psoriasis arthritis.
Kowalzick L; Bertolini J; Baumann C; Walther B; Truhm B; Eickenscheidt L
J Dtsch Dermatol Ges; 2013 May; 11(5):447-9. PubMed ID: 23343137
[No Abstract] [Full Text] [Related]
14. Review of 26 cases of classical pyoderma gangrenosum: clinical and therapeutic features.
Vidal D; Puig L; Gilaberte M; Alomar A
J Dermatolog Treat; 2004 Jun; 15(3):146-52. PubMed ID: 15204146
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of etanercept in an integrated multistudy database of patients with psoriasis.
Gordon K; Korman N; Frankel E; Wang H; Jahreis A; Zitnik R; Chang T
J Am Acad Dermatol; 2006 Mar; 54(3 Suppl 2):S101-11. PubMed ID: 16488320
[TBL] [Abstract][Full Text] [Related]
16. Etanercept therapy for psoriasis in a patient with concomitant hepatitis C and liver transplant.
Collazo MH; González JR; Torres EA
P R Health Sci J; 2008 Dec; 27(4):346-7. PubMed ID: 19069362
[TBL] [Abstract][Full Text] [Related]
17. Safety of etanercept therapy in a patient with psoriasis, Down's syndrome and concomitant hepatitis C virus infection.
Alcaide AJ; Barrera MV; Habicheyn S; López N; Mendiola MV; Herrera E
J Eur Acad Dermatol Venereol; 2008 Dec; 22(12):1514-6. PubMed ID: 18355196
[No Abstract] [Full Text] [Related]
18. A case report of successful treatment of pyoderma gangrenosum in a patient with autoimmune hepatitis, and review of the literature.
Androutsakos T; Stamopoulos P; Aroni K; Hatzis G
BMC Gastroenterol; 2015 Oct; 15():149. PubMed ID: 26502871
[TBL] [Abstract][Full Text] [Related]
19. The role of anti-tumor necrosis factor-alpha therapy in Pyoderma gangrenosum associated with inflammatory bowel disease.
Reguiaï Z; Grange F
Am J Clin Dermatol; 2007; 8(2):67-77. PubMed ID: 17428111
[TBL] [Abstract][Full Text] [Related]
20. Etanercept as a salvage treatment for refractory aplastic anemia.
Dufour C; Giacchino R; Ghezzi P; Tonelli R; Ferretti E; Pitto A; Pistoia V; Lanza T; Svahn J
Pediatr Blood Cancer; 2009 Apr; 52(4):522-5. PubMed ID: 19061218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
